We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Apr 2022 to Apr 2024
By Cecilia Butini
Bayer AG on Tuesday backed its 2022 financial objectives after third-quarter sales beat expectations and it reported earnings growth in all its segments.
The German pharmaceutical-and-agricultural company posted net profit of 546 million euros ($547.2 million) for the period, up from EUR85 million the year prior, when its agricultural division was in a recovery phase. Earnings before interest, taxes, depreciation and amortization before special items--a closely-watched metric--was EUR2.45 billion for the period, up from EUR2.09 billion the year prior.
Sales rose to EUR11.28 billion for the quarter from EUR9.78 billion the year prior.
Both sales and Ebitda before special items beat analysts' expectations, while net profit came slightly short.
Bayer backed its 2022 view, and Chief Executive Werner Baumann said the company is right on track to achieve the full-year outlook it raised in August.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
November 08, 2022 02:09 ET (07:09 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
